LONNEL COATS

Insider Reports History

Location
The Woodlands, TX
Signature
/s/ Soo-Yeun Lim, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by LONNEL COATS:

Company Role Class Num Shares Value Price $ Report Date Ownership
LEXICON PHARMACEUTICALS, INC. Chief Executive Officer, Director Common Stock 1,098,068 $2,876,938 $2.62 28 Feb 2024 Direct
LEXICON PHARMACEUTICALS, INC. Chief Executive Officer, Director Restricted Stock Units 240,767 $630,810 $2.62 28 Feb 2024 Direct
Blueprint Medicines Corp Director Stock Option (Right to Buy) 0 $47,852 $15.01 17 Jul 2025 Direct
Blueprint Medicines Corp Director Common Stock 0 $0 $101.84 17 Jul 2025 Direct
LEXICON PHARMACEUTICALS, INC. Chief Executive Officer, Director Stock Option (Right to Buy) 770,420 08 Feb 2024 Direct
Relay Therapeutics, Inc. Director Stock Option (Right to Buy) 207,931 04 Nov 2025 Direct
Verve Therapeutics, Inc. Director Stock Option (right to buy) 0 25 Jul 2025 Direct

Insider Reports Filed by LONNEL COATS

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RLAY Relay Therapeutics, Inc. 04 Nov 2025 1 $0 4 Director 06 Nov 2025, 16:37
RLAY Relay Therapeutics, Inc. 04 Nov 2025 0 $0 3 Director 06 Nov 2025, 16:28
VERV Verve Therapeutics, Inc. 25 Jul 2025 2 $0 4 Director 28 Jul 2025, 17:15
BPMC Blueprint Medicines Corp 17 Jul 2025 10 $0 4 Director 21 Jul 2025, 19:49
BPMC Blueprint Medicines Corp 18 Jun 2025 1 +$49,992,424 4 Director 24 Jun 2025, 16:20
VERV Verve Therapeutics, Inc. 05 Jun 2025 1 $0 4 Director 06 Jun 2025, 17:01
BPMC Blueprint Medicines Corp 20 Nov 2024 8 -$1,246,206 4 Director 22 Nov 2024, 16:47
VERV Verve Therapeutics, Inc. 26 Jun 2024 1 $0 4 Director 28 Jun 2024, 07:45
BPMC Blueprint Medicines Corp 12 Jun 2024 2 $0 4 Director 14 Jun 2024, 17:37
LXRX LEXICON PHARMACEUTICALS, INC. 28 Feb 2024 7 -$160,792 4 Chief Executive Officer, Director 29 Feb 2024, 16:26
LXRX LEXICON PHARMACEUTICALS, INC. 08 Feb 2024 2 $0 4 Chief Executive Officer, Director 12 Feb 2024, 16:12
LXRX LEXICON PHARMACEUTICALS, INC. 16 Nov 2023 1 +$94,797 4 Chief Executive Officer, Director 17 Nov 2023, 16:55
LXRX LEXICON PHARMACEUTICALS, INC. 10 Nov 2023 1 +$10,100 4 Chief Executive Officer, Director 13 Nov 2023, 17:31
LXRX LEXICON PHARMACEUTICALS, INC. 29 Jun 2023 1 +$21,600 4 Chief Executive Officer, Director 29 Jun 2023, 16:13
LXRX LEXICON PHARMACEUTICALS, INC. 23 Jun 2023 2 +$46,742 4 Chief Executive Officer, Director 26 Jun 2023, 16:04
LXRX LEXICON PHARMACEUTICALS, INC. 22 Jun 2023 1 +$92,400 4 Chief Executive Officer, Director 22 Jun 2023, 16:01
BPMC Blueprint Medicines Corp 21 Jun 2023 2 +$5,300 4 Director 23 Jun 2023, 19:04
VERV Verve Therapeutics, Inc. 15 Jun 2023 1 $0 4 Director 20 Jun 2023, 17:00
LXRX LEXICON PHARMACEUTICALS, INC. 28 Feb 2023 7 -$110,607 4 Chief Executive Officer, Director 01 Mar 2023, 15:46
LXRX LEXICON PHARMACEUTICALS, INC. 09 Feb 2023 2 $0 4 Chief Executive Officer, Director 13 Feb 2023, 15:55
VERV Verve Therapeutics, Inc. 08 Aug 2022 1 $0 4 Director 09 Aug 2022, 17:05
VERV Verve Therapeutics, Inc. 08 Aug 2022 0 $0 3 Director 09 Aug 2022, 17:00
BPMC Blueprint Medicines Corp 21 Jun 2022 2 $0 4 Director 30 Jun 2022, 21:57
LXRX LEXICON PHARMACEUTICALS, INC. 28 Feb 2022 7 -$136,951 4 Chief Executive Officer, Director 28 Feb 2022, 18:11
LXRX LEXICON PHARMACEUTICALS, INC. 10 Feb 2022 2 $0 4 Chief Executive Officer, Director 14 Feb 2022, 15:05
BPMC Blueprint Medicines Corp 02 Jun 2021 2 $0 4 Director 04 Jun 2021, 16:19